National Institute of Diabetes and Digestive and Kidney Diseases

The DCCT/EDIC has been supported by U01 Cooperative Agreement grants and contracts with the Division of Diabetes Endocrinology and Metabolic Diseases of the National Institute of Diabetes and Digestive and Kidney Diseases, and through support by the National Eye Institute, the National Institute of Neurologic Disorders and Stroke, the General Clinical Research Centers Program (1993–2007), and the Clinical and Translational Science Center Program (2006-present), Bethesda, Maryland, USA. Trial Registration: www.clinicaltrials.gov; identifiers NCT00360815 and NCT00360893.

Supporting Contributors Over Time: The DCCT/EDIC study has been supported by several commercial entities that have provided free or discounted supplies or equipment for participant use. These include: Abbott Diabetes Care - Alameda, CA; Animas® Corporation - Westchester, PA; Bayer HealthCare LLC Diabetes Care, North America Headquarters - Tarrytown; NY Becton Dickinson and Company - Franklin Lakes, NJ; Dex4® (formerly CanAm) - Atlanta, GA; Eli Lilly and Company - Indianapolis, IN; Genentech - San Francisco, CA; Lifescan - Milpitas, CA; Medtronic MiniMed, Inc. - Minneapolis, MI; Omron Corporation - Shelton, CT; OmniPod® Insulin Management System - Bedford, MA; Roche Diabetes Care - Indianapolis, IN; Sanofi-Aventis U.S. LLC - Bridgewater, NJ. These commercial entities were not involved in the design or conduct of the DCCT/EDIC.